A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Randomized, Double Blind, Clinical Study for Evaluating the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis. Controlled Study vs Placebo

Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.

Main Inclusion Criteria:

• Good general health
• Phototype I to IV
• Mild to moderate SCORAD (between 15 and 25)

Main Exclusion Criteria:

• Pregnant/breastfeeding female or who have planned a pregnancy during the study period
• Positive history for atopy or hypersensitive skin
• Subjects under systemically pharmacological treatment
• Subjects under locally pharmacological treatment on the skin area monitored during the test
• Subjects with congenital or acquired immunodeficiency
• Subjects under treatment with food supplements which could interfere with the functionality of the product under study
• Subjects which show other skin alterations on the monitored area except for acne lesions
• Subjects with known or suspected sensitization to one or more test formulation ingredients